Our Services
Medical Information
Helpful Resources
Published on: 12/28/2025
Yes, pregnancy is often possible after early-stage cervical cancer treatment, particularly following a cone biopsy or radical trachelectomy. Studies show about 50% of people who try to conceive after a trachelectomy succeed, and most pregnancies result in live births—though preterm delivery risk is higher.
Key factors that influence fertility include cancer stage, treatment type, timing before trying to conceive, and access to high-risk obstetric care. Fertility-sparing options may preserve your ability to carry a pregnancy, while hysterectomy or chemoradiation typically end natural fertility.
Because outcomes vary widely based on your specific symptoms, diagnosis, and treatment history, understanding your situation clearly is the critical first step. Take a free, instant, online symptom check to help identify what may be going on, clarify your next questions for your doctor, and confidently navigate your next steps toward the right care.
Reviewed for medical accuracy: 07/09/2026
Can You Get Pregnant After Cervical Cancer Treatment?
Many women diagnosed with early‐stage cervical cancer hope to preserve their fertility and start or complete their families. Advances in surgical techniques and careful patient selection have made pregnancy after treatment possible for some—but it isn't guaranteed, and there are important trade-offs to understand. Below, we'll review treatment options, pregnancy outcomes, risks and timing, plus practical tips to help you and your doctor make informed decisions.
• Cone biopsy (cervical conization)
– Removes a cone‐shaped piece of the cervix containing the tumor
– Usually reserved for very early (stage IA1) disease without lymph-vascular invasion
– Fertility impact is minimal; most women retain normal cervical function
• Radical trachelectomy (cervix removal plus uterine preservation)
– Removes cervix, surrounding tissue and upper vagina, spares the uterine body
– Often combined with a cerclage (cervical stitch) to reduce preterm risk
– Main fertility-sparing option for stage IA2–IB1 disease
• Radical hysterectomy
– Removes uterus and cervix, ending natural childbearing ability
– May be offered when cancer is slightly more advanced or fertility is not a concern
• Chemoradiation
– Radiation to the pelvis often damages ovaries and uterine blood supply
– Concurrent chemotherapy adds ovarian toxicity
– Fertility is usually lost; ovarian transposition (moving ovaries out of radiation field) can help preserve hormonal function, but pregnancy remains very unlikely
• Li et al. (2014), Int J Gynecol Cancer
– 300+ women underwent radical trachelectomy for stage IA2–IB1
– 50% attempted pregnancy; among them, 60–70% achieved pregnancy
– Live birth rate was approximately 65–75% of pregnancies
• Bentivegna et al. (2016), Gynecol Oncol (meta-analysis)
– Pooled data from multiple centers, >800 patients
– Overall pregnancy rate 52%; live birth rate 70% of those pregnancies
– Nearly one-third of births were premature (before 37 weeks)
Key takeaways:
– About half of women who try conceive after trachelectomy will become pregnant.
– When pregnancy occurs, most result in live births, but preterm delivery is common.
• Cervical insufficiency
– Less cervical tissue means higher risk of miscarriage or preterm labor
– A permanent cerclage is often placed during surgery; additional cerclage may be needed later
• Preterm birth
– Up to 30–40% deliver before 37 weeks
– Premature infants may require neonatal intensive care
• Fertility delays
– Doctors generally recommend waiting 6–12 months after surgery to confirm no cancer recurrence before trying to conceive
– Delays can lower fertility, especially if you're older or have other risk factors
• Monitoring and high-risk OB care
– Pregnancy after trachelectomy is considered high risk
– Regular cervical length checks by ultrasound
– Close coordination between gynecologic oncologist and maternal-fetal medicine specialist
• Wait for clear scans and exams
– Most protocols require at least two years of disease-free follow-up before pregnancy attempts
– Early recurrence risk is highest in the first 12–18 months
• Assess ovarian reserve
– Age is the single biggest factor in fertility
– Your doctor may check hormone levels (FSH, AMH) to estimate egg supply
• Consider assisted reproductive technologies
– For those with borderline ovarian reserve or other infertility factors
– Egg or embryo freezing before treatment may be an option
• Uterine donation and surrogacy
– Experimental and legally complex; not widely available
– Requires careful ethical, medical and legal review
• Adoption
– A fulfilling alternative path to parenthood
• Egg donation with surrogacy
– Your embryos carried by another woman
• Preserve fertility early if needed
– If cancer treatment threatens ovarian function, ask about egg or embryo freezing before surgery or radiation
• Track health and symptoms
– Be vigilant for any new symptoms during follow-up care
– If you're experiencing any unusual symptoms or want to understand your risk factors better, use Ubie's free AI-powered cervical cancer symptom checker to get personalized insights in just minutes
• Emotional support matters
– Fertility challenges after cancer can be stressful
– Seek counseling, support groups or peer networks
Speak to a doctor about any concerns that could be life-threatening or serious.
Conclusion
Pregnancy after cervical cancer treatment is possible for many women, especially those who qualify for fertility-sparing procedures like cone biopsy or radical trachelectomy. Success rates vary—about half of women trying to conceive after trachelectomy achieve pregnancy, and most of those result in live births, albeit with higher rates of preterm delivery. Careful planning, close monitoring and a supportive medical team can improve outcomes. Always discuss your individual case in depth with your oncology and fertility specialists to weigh the benefits and risks.
(References)
Li J, Li JJ, Liu Y, Gao Y, & Zhong XY. (2014). Pregnancy outcomes after radical trachelectomy for early-stage cervical… Int J Gynecol Cancer, 24246121.
Bentivegna E, Ruscito I, Magné N, Castelnau-Marchand P, & Morice P. (2016). Oncological and obstetrical outcomes after fertility-sparing… Gynecol Oncol, 28755718.
American Association for the Study of Liver Diseases. (2018). AASLD practice guidance on the management of decompensated… Hepatology, 30322807.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.